Z hao Yan is the chairman and CEO of Bloomage Biotechnology, the world's largest producer of hyaluronic acid. She acquired the company in 2001 and transformed it from a raw material supplier into a diversified biotech giant. Under her leadership, Bloomage expanded into end products, launching successful skincare brands like Biohyalux and incorporating hyaluronic acid into foods and beverages.
Zhao is known as the "Queen of Hyaluronic Acid" in China. She holds a degree in biology and has a background in real estate and finance investments. She took Bloomage public on the Hong Kong Stock Exchange before privatizing it and re-listing it on the Shanghai STAR Market in 2019. Her business empire also includes interests in real estate, finance, and sports, making her one of China's wealthiest self-made women.
Advertisement
Zhao Yan is a Chinese businesswoman, the chairman and CEO of Shanghai-listed Bloomage Biotechnology (SHA: 688363), a biotech company best known for making hyaluronic acid, an ingredient widely used in beauty products.
Her company has moved beyond being just a supplier, establishing its own skincare brands (including the Biohyalux line for facial creams, gels and masks) and diversifying into consumer products like candies and bottled water infused with the compound.
Zhao Yan's career is defined by her strategic vision to monetize a core biotech ingredient (hyaluronic acid) across multiple consumer platforms. She successfully transformed Bloomage from a bulk supplier to a diversified brand owner in the high-growth cosmetics and wellness sectors.
Her structural contribution is tied to building the Biohyalux skincare line and expanding the use of hyaluronic acid into food and beverages, capturing market share in China's massive wellness trend. She also has private interests in finance, property and sports.
Advertisement
Founds and chairs Bloomage Biotechnology.
Establishes skincare brands like Biohyalux and diversifies into hyaluronic acid-infused food and water.
Continues as Chairman and CEO.
Zhao Yan's wealth is concentrated in her controlling stake and continued leadership of the publicly traded biotech giant, Bloomage Biotechnology.
Advertisement
Advertisement
No publicly available quotes.
Advertisement
+1.37% | +$51.72M
-0.49% | -$29.48M
This profile is compiled from verified biographical and financial records:
All information is cross-referenced with public sources for accuracy; some narrative sections are AI-assisted summaries.
If you find any inaccuracies, please report them to admin@redcarpetlife.in
Sponsored Content